Evolus, Inc. (EOLS) vs Kamada Ltd. (KMDA)
- Evolus, Inc. EOLS 7.10 −6.21%
- Kamada Ltd. KMDA 7.77 −0.77%
Evolus, Inc. and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. is the larger, with a market value of $500.0M against $451.7M — 1.1× the size. Evolus, Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 20.4×. Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 13.2%. Kamada Ltd. has the higher net margin (11.6% vs −10.9%) and the higher return on invested capital (8.47% vs −14.5%). Across the 18 metrics below, Kamada Ltd. leads on 11 and Evolus, Inc. on 7.
Valuation
Profitability
| Metric | EOLS | KMDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.74% | 40.82% | 53.94% |
| Operating margin | (5.90%) | 14.51% | 0.00% |
| Net margin | (10.85%) | 11.60% | 0.00% |
| Free cash flow margin | (6.92%) | 13.72% | 0.00% |
| Return on equity | 138.57% | 8.40% | (0.40%) |
| Return on assets | (14.40%) | 5.92% | (3.32%) |
| Return on invested capital | (14.47%) | 8.47% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack